ClinicalTrials.gov
public full text
Public Domain
Empirical Meropenem Versus Piperacillin/Tazobactam for Adult Patients With Sepsis
The EMPRESS trial aims to test the two most commonly used antibiotics (meropenem and piperacillin/tazobactam) among intensive care patients with sepsis (blood poisoning), as the safety of these two drugs is unclear in this group of patients.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- PipEracillin Tazobactam Versus mERoPENem for Treatment of Bloodstream Infections Caused by Cephalosporin-resistant Enterobacteriaceae (PETERPEN)#201819
- Piperacillin Pharmacokinetics in ICU Patients#895688
- A Pharmacokinetics Study of Meropenem and Piperacillin in Patients With Sepsis#1127741
- Repository for Sepsis and Postresuscitation Samples#825506
- Antibiotic Administration and Blood Culture Positivity in Severe Sepsis and Septic Shock#1153722
Record · ID 1087387
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive